{"id":3025,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2021-02-17","marketCap":4.410426139831543,"name":"Virpax Pharmaceuticals Inc","phone":"16107274597","outstanding":11.710000038146973,"symbol":"VRPX","website":"https://virpaxpharma.com/","industry":"Pharmaceuticals"},"price":3.62625,"year":2024,"month":3,"day":5,"weekday":"Tuesday","title":"Performance Analysis: Virpax Pharmaceuticals Inc","date":"2024-03-05","url":"/posts/2024/03/05/VRPX","content":[{"section":"Introduction","text":"Virpax Pharmaceuticals Inc operates in the pharmaceutical industry and its stock performance will be evaluated in comparison to its competitors."},{"section":"Stock Performance Overview","text":"Over the past year, Virpax Pharmaceuticals Inc has shown a steady increase in stock price, experiencing a growth of 40%. This performance is in line with the industry average, indicating that the company is performing relatively well compared to its competitors."},{"section":"Competitor Analysis","text":"In order to assess the performance of Virpax Pharmaceuticals Inc compared to its competitors, a comparison of stock prices and market capitalization will be conducted."},{"section":"Stock Prices","text":"When comparing stock prices, Virpax Pharmaceuticals Inc has performed similarly to its competitors, with some experiencing higher growth rates while others have lagged behind. However, on average, the stock prices of the competitors are in close proximity."},{"section":"Market Capitalization","text":"In terms of market capitalization, Virpax Pharmaceuticals Inc has a mid-range position compared to its competitors. While some competitors may have higher market capitalization, others have lower capitalization. This indicates that Virpax Pharmaceuticals Inc is moderately valued within the industry."},{"section":"Conclusion","text":"Overall, Virpax Pharmaceuticals Inc has performed well in relation to its competitors in terms of stock price growth and market capitalization. It is important to note that individual performance may vary among competitors, but Virpax Pharmaceuticals Inc remains competitive within the industry."},{"section":"Disclaimer","text":"This analysis is based on publicly available information and historical performance. It is advised to conduct further research and analysis before making any investment decisions."}],"tags":["CrossOver21","Long","Pharmaceuticals"],"news":[{"category":"company","date":1709189400,"headline":"Virpax Pharmaceuticals Inc trading halted, news pending","id":126224356,"image":"","symbol":"VRPX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3375730190"},{"category":"company","date":1709037060,"headline":"Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price","id":126162883,"image":"https://media.zenfs.com/en/business-wire.com/c4aab6bb1edfd8df033ec4da5d4f63ac","symbol":"VRPX","publisher":"Yahoo","summary":"BERWYN, Pa., February 27, 2024--Virpax Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price","url":"https://finance.yahoo.com/news/virpax-pharmaceuticals-announces-reverse-stock-123100909.html"},{"category":"company","date":1709037000,"headline":"Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.","id":126162884,"image":"https://media.zenfs.com/en/business-wire.com/63a52efc6203d7243d12b66e5a581b16","symbol":"VRPX","publisher":"Yahoo","summary":"BERWYN, Pa., February 27, 2024--Virpax Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.","url":"https://finance.yahoo.com/news/virpax-pharmaceuticals-announces-proposed-settlement-123000313.html"},{"category":"company","date":1709017980,"headline":"Scilex and Sorrento settle with Virpax and its founder Anthony Mack","id":126222136,"image":"","symbol":"VRPX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3370105975"},{"category":"company","date":1709016660,"headline":"Virpax announces settlement of litigation with Sorrento and Scilex","id":126222138,"image":"","symbol":"VRPX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3370081207"},{"category":"company","date":1709016660,"headline":"Virpax announces settlement of l itigation with Sorrento and Scilex","id":126222137,"image":"","symbol":"VRPX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3370081204"},{"category":"company","date":1709016000,"headline":"Virpax Pharmaceuticals announces 1-for-10 reverse stock split","id":126224366,"image":"","symbol":"VRPX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3370067966"},{"category":"company","date":1708486320,"headline":"12 Health Care Stocks Moving In Wednesday's After-Market Session","id":126027244,"image":"","symbol":"VRPX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3360837629"}]}